Skip to main content

Peer Review reports

From: Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells

Original Submission
21 Apr 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
19 Aug 2016 Editorially accepted
31 Aug 2016 Article published 10.1186/s12885-016-2730-2

You can find further information about peer review here.

Back to article page